NCT02056782 2023-02-21
PGX-AML
Jazz Pharmaceuticals
Phase 1 Completed
Clinical Trials
4 trialsNCT01461915 2022-06-06
PGPC1
Jazz Pharmaceuticals
Phase 2 Terminated
NCT02995655 2019-12-05
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Washington University School of Medicine
Phase 1 Completed
NCT02164097 2017-12-22
ODSH + ICE Chemotherapy in Pediatric Solid Tumors
New York Medical College
Phase 1 Terminated